FULGENZI, Claudia Angela Maria, CHEON, Jaekyung, BETTINGER, Dominik, CHON, Hong Jae und PINATO, David James, 2022. Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study. Freiburg: Universität.
Elsevier - Harvard (with titles)Fulgenzi, C.A.M., Cheon, J., Bettinger, D., Chon, H.J., Pinato, D.J., 2022. Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study. Universität, Freiburg. https://doi.org/10.1016/j.ejca.2022.08.024
American Psychological Association 7th editionFulgenzi, C. A. M., Cheon, J., Bettinger, D., Chon, H. J., & Pinato, D. J. (ca. 2022). Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study [Cd]. Universität. https://doi.org/10.1016/j.ejca.2022.08.024
Springer - Basic (author-date)Fulgenzi CAM, Cheon J, Bettinger D, Chon HJ, Pinato DJ (2022) Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study. Universität, Freiburg
Juristische Zitierweise (Stüber) (Deutsch)Fulgenzi, Claudia Angela Maria/ Cheon, Jaekyung/ Bettinger, Dominik/ Chon, Hong Jae/ Pinato, David James, Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study, Freiburg 2022.